首页> 外文期刊>Nucleic Acids Research >Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II
【24h】

Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II

机译:Leishmania donovani拓扑异构酶II的'Gyr A'部分中DNA结合结构域的表征和活性位点残基的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

DNA topoisomerase II is a multidomain homodimeric enzyme that changes DNA topology by coupling ATP hydrolysis to the transport of one DNA helix through a transient double-stranded break in another. To investigate the biochemical properties of the individual domains of Leishmania donovani topoisomerase II, four truncation mutants were generated. Deletion of 178 aminoacids from the C-terminus (core and Ld Delta C1058) had no apparent effect on the DNA-binding or cleavage activities of the enzymes. However, when 429 aminoacids from the N-terminus and 451 aminoacids from the C-terminus were removed (Ld Delta N Delta C), the enzyme was no longer active. Moreover, the removal of 429 aminoacids from the N-terminus (Ld Delta N Delta C, core and Ld Delta N429) render the mutant proteins incapable of performing ATP hydrolysis. The mutant proteins show cleavage activities at wide range of KCl concentrations (25-350 mM). In addition, the mutant proteins, excepting Ld Delta N Delta C, can also act on kDNA and linearize the minicircles. Surprisingly, the mutant proteins fail to show the formation of the enhanced cleavable complex in the presence of etoposide. Our findings suggest that the conformation required for interaction with the drug is absent in the mutant proteins. Here, we have also identified Tyr(775) through direct sequencing of the DNA linked peptide as the catalytic residue implicated in DNA-breakage and rejoining. Taken together, our results demonstrate that topoisomerase II are functionally and mechanistically conserved enzymes and the variations in activity seem to reflect functional optimization for its physiological role during parasite genome replication.
机译:DNA拓扑异构酶II是一种多域同型二聚体酶,通过将ATP水解偶联到一个DNA螺旋的转运中,通过另一个瞬时的双链断裂来改变DNA拓扑。为了研究利什曼原虫多诺万拓扑异构酶II的各个域的生化特性,生成了四个截断突变体。从C末端(核心和Ld Delta C1058)缺失178个氨基酸对酶的DNA结合或切割活性没有明显影响。但是,当N端的429个氨基酸和C端的451个氨基酸被去除时(Ld Delta N Delta C),该酶不再具有活性。此外,从N-末端(Ld Delta N Delta C,核心和Ld Delta N429)除去429个氨基酸使突变蛋白无法进行ATP水解。突变蛋白在宽范围的KCl浓度(25-350 mM)下显示出切割活性。此外,除Ld Delta N Delta C外的突变蛋白也可以作用于kDNA并使线性微环线性化。令人惊讶地,在依托泊苷存在下,突变蛋白未能显示出增强的可切割复合物的形成。我们的发现表明突变蛋白中不存在与药物相互作用所需的构象。在这里,我们还通过对DNA连接肽的直接测序鉴定了Tyr(775),这是涉及DNA断裂和重新结合的催化残基。两者合计,我们的结果表明,拓扑异构酶II是功能和机制上保守的酶,活性的变化似乎反映了寄生虫基因组复制过程中对其生理作用的功能优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号